Table 1 Body weights at week 104 of the experimental period
Test article | Total dose (mg/kg) | Male (g) | Female (g) | ||
|---|---|---|---|---|---|
Nontreatment | - | 412.0 ± 35.7 | (29) | 261.9 ± 36.8 | (22) |
Control | 0 | 421.6 ± 47.3 | (26) | 272.6 ± 16.2 | (28) |
MWNT-7 | 0.128 | 412.5 ± 42.1 | (28) | 272.9 ± 36.0 | (28) |
MWNT-7 | 0.64 | 417.8 ± 39.3 | (16) | 258.1 ± 32.3 | (26) |
MWNT-7 | 3.2 | 405.4 | (1) | 269.1 ± 17.3 | (15) |
VGCF™-H | 0.128 | 412.5 ± 64.6 | (26) | 264.1 ± 43.5 | (30) |
VGCF™-H | 0.64 | 413.3 ± 46.3 | (35) | 270.5 ± 29.9 | (31) |
VGCF™-H | 3.2 | 417.8 ± 44.9 | (30) | 274.0 ± 17.6 | (31) |